Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term pathology. Found 667 abstracts

no pagination
Cohen EE, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England). 2019 Jan 12;393(10167):156-67.
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Jones CE, Hammer AM, Cho Y, Sizemore GM, Cukierman E, Yee LD, Ghadiali SN, Ostrowski MC, Leight JL. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia (New York, NY). 2019 Jan;21(1):132-45.   PMCID: PMC6293034
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Zamanova S, Shabana AM, Mondal UK, Ilies MA. Carbonic anhydrases as disease markers. Expert opinion on therapeutic patents. 2019 Jul;29(7):1-25.   PMCID: PMC6612586
Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science (New York, NY). 2018 Nov 30;362(6418):1055-60.   PMCID: PMC6475924
Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DY, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer. 2018 Oct 22;6(1):109.   PMCID: PMC6196426
Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. Journal of cellular physiology. 2018 Jan;233(1):409-21.   PMCID: PMC5592128
Chang WL, Jackson C, Riel S, Cooper HS, Devarajan K, Hensley HH, Zhou Y, Vanderveer LA, Nguyen MT, Clapper ML. Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas. Gut. 2018 Jul;67(7):1290-8.   PMCID: PMC6031273
Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018 Mar 27;19(1):205.   PMCID: PMC5870194
Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, Kossenkov AV, Hazen SL, Trinchieri G, Grivennikov SI, Koltsova EK. An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. 2018 Nov 20;49(5):943-957e9.   PMCID: PMC6257980
Gerson JN, Ramamurthy C, Borghaei H. Managing adverse effects of immunotherapy. Clinical advances in hematology & oncology : H&O. 2018 May;16(5):364-74.   PMCID: Review
Gettinger S, Hellmann MD, Chow LQ, Borghaei H, Antonia S, Brahmer JR, Goldman JW, Gerber DE, Juergens RA, Shepherd FA, Laurie SA, Young TC, Li X, Geese WJ, Rizvi N. Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC. J Thorac Oncol. 2018 Sep;13(9):1363-72.
Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clinical advances in hematology & oncology : H&O. 2018 Oct;16(10):677-86.
Gomez K, Miura S, Huuki LA, Spell BS, Townsend JP, Kumar S. Somatic evolutionary timings of driver mutations. BMC cancer. 2018 Jan 18;18(1):85.   PMCID: PMC5774140
Hahn NM, Necchi A, Loriot Y, Powles T, Plimack ER, Sonpavde G, Roupret M, Kamat AM. Role of Checkpoint Inhibition in Localized Bladder Cancer. European urology oncology. 2018 Aug;1(3):190-8.
Haifler M, Pence I, Sun Y, Kutikov A, Uzzo RG, Mahadevan-Jansen A, Patil CA. Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy. Journal of biophotonics. 2018 Jun;11(6):e201700188.
Handra-Luca A, Wei S. Intrathyroid cystic thyroglossal duct remnant and ectopic thymus: a fortuitous or development-related association?. Surgery today. 2018 Aug;48(8):815-8.
Harshman LC, Chen YH, Liu G, Carducci MA, Jarrard D, Dreicer R, Hahn N, Garcia JA, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack ER, Cooney M, Vogelzang NJ, Picus J, Dipaola R, Sweeney CJ. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 Feb;36(4):376-82.   PMCID: PMC5805480
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Practical radiation oncology. 2018 Jan;8(1):40-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term pathology

pathology Male therapeutic use drug therapy genetics Middle Aged Aged metabolism Female Adult Antineoplastic Agents 80 and over Aged adverse effects administration & dosage Mice Antineoplastic Combined Chemotherapy Protocols Signal Transduction Prostatic Neoplasms Kidney Neoplasms etiology Neoplasm Metastasis antagonists & inhibitors methods Neoplastic Gene Expression Regulation Tumor Cell Line Disease Progression CTLA-4 Antigen mortality Randomized Controlled Trials as Topic Renal Cell Carcinoma therapy B7-H1 Antigen Monoclonal Antibodies-Humanized enzymology Treatment Outcome physiology Docetaxel Neoplasm Invasiveness pharmacology Nivolumab Kaplan-Meier Estimate Programmed Cell Death 1 Receptor prevention & control immunology Head and Neck Neoplasms secondary Cell Movement Urinary Bladder Neoplasms Monoclonal Antibodies Retrospective Studies Prostate Hydroxymethylglutaryl-CoA Reductase Inhibitors Comparative Effectiveness Research Thyroglosal duct Progression-Free Survival Collagen Proto-Oncogene Proteins c-kit Gene Expression Membrane Glycoproteins Gene Knockdown Techniques Neoplasms human psychology Neoadjuvant Therapy extracellular matrix Radiosurgery Clonal Evolution Enzymologic Gene Expression Regulation RNA Interference matrix metalloproteinases Therapy Colorectal Neoplasms Pyrimidines Tyrosine kinase inhibitor Thyroid Diseases Squamous Cell Carcinoma of Head and Neck Hepatitis Genomics Infrared Rays Lung Neoplasms Clear Cell Adenocarcinoma Non-muscle-invasive Mutation Immune checkpoint inhibitor Angiogenesis Inhibitors Kallikreins Melanoma Sunitinib Skin Neoplasms Vascular Endothelial Growth Factor A epidemiology Programmed death 1 axis inhibitor Extracellular Matrix neoplasm invasion Cysts Il-22 blood Maintenance Chemotherapy surgery Intracellular Signaling Peptides and Proteins Atorvastatin Calcium Cisplatin Fibroblasts Carcinogenesis Homeostasis Transitional Cell Carcinoma pd-1 cytokines Cell Cycle Checkpoints Hbme1 Local Neoplasm Recurrence Somatic mutation Immunophenotyping Carcinoma Genetic Heterogeneity Attitudes Health Knowledge-Practice Non-Small-Cell Lung Carcinoma CD138 pd-l1 Piperazines cancer prevention Cyst Animal Mammary Glands Metastatic renal cell carcinoma Pancreatic Neoplasms Hematologic Neoplasms Animal Disease Models Raman spectroscopy Diet Parathyroid Glands deficiency Lipid Metabolism Patient Dropouts Pazopanib Interleukins Urothelium Mitogen-Activated Protein Kinases biomarker ctla-4 Preclinical Drug Evaluation cytology Experimental Melanoma Dermatitis adverse Thyroid Adenocarcinoma Double-Blind Method Sulindac Phthalazines Sulfonamides
Last updated on Friday, December 06, 2019